KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Leases (2018 - 2025)

Historic Leases for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $738.0 million.

  • Moderna's Leases fell 586.73% to $738.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $738.0 million, marking a year-over-year decrease of 586.73%. This contributed to the annual value of $759.0 million for FY2024, which is 645.16% up from last year.
  • Moderna's Leases amounted to $738.0 million in Q3 2025, which was down 586.73% from $750.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Leases ranged from a high of $1.2 billion in Q3 2022 and a low of $99.0 million during Q1 2021
  • Over the past 5 years, Moderna's median Leases value was $750.0 million (recorded in 2025), while the average stood at $745.7 million.
  • Per our database at Business Quant, Moderna's Leases soared by 63888.89% in 2021 and then tumbled by 3800.0% in 2023.
  • Over the past 5 years, Moderna's Leases (Quarter) stood at $665.0 million in 2021, then soared by 72.93% to $1.2 billion in 2022, then crashed by 38.0% to $713.0 million in 2023, then rose by 6.45% to $759.0 million in 2024, then fell by 2.77% to $738.0 million in 2025.
  • Its Leases stands at $738.0 million for Q3 2025, versus $750.0 million for Q2 2025 and $752.0 million for Q1 2025.